These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17236409)

  • 1. [Cardiovascular risk and estrogens].
    Franeková J; Koliba P; Jabor A; Pohlídal A; Holub Z
    Ceska Gynekol; 2006 Dec; 71(6):483-9. PubMed ID: 17236409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism].
    García L; Hernández I; Cervera Aguilar R; Ayala AR
    Ginecol Obstet Mex; 2001 Sep; 69():351-4. PubMed ID: 11816532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implications.
    Smolders RG; van der Mooren MJ; Sipkema P; Kenemans P
    Gynecol Endocrinol; 2003 Aug; 17(4):339-54. PubMed ID: 14503980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of atherogenetic biomarkers and estradiol changes in postmenopause.
    Ratiani L; Parkosadze G; Koptonashvili L; Ormotsadze G; Sulaqvelidze M; Sanikidze T
    Georgian Med News; 2011 Jun; (195):100-5. PubMed ID: 21778553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
    Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hormone replacement therapy on the cardiovascular system].
    Payer J
    Cas Lek Cesk; 2001 Feb; 140(3):67-9. PubMed ID: 11284420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma orexin-A levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status.
    El-Sedeek MSh; Korish AA; Deef MM
    BJOG; 2010 Mar; 117(4):488-92. PubMed ID: 20105164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials.
    Stevenson JC; Chines A; Pan K; Ryan KA; Mirkin S
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2329-38. PubMed ID: 25894963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogen on the vascular wall: vasomotor function and inflammation.
    Koh KK
    Cardiovasc Res; 2002 Sep; 55(4):714-26. PubMed ID: 12176121
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogens and the cardiovascular system: role of estradiol metabolites in hormone replacement therapy.
    Lippert TH; Seeger H; Mueck AO
    Climacteric; 1998 Dec; 1(4):296-301. PubMed ID: 11907937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and postmenopausal hormone replacement therapy.
    Jensen J
    Br J Clin Pract Suppl; 1996 Sep; 86():6-8. PubMed ID: 8995003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natural estrogens and the cardiovascular system].
    Bader A; Sacrez J; Langer B; Sacrez A
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):233-7. PubMed ID: 8767217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
    Gaspard UJ
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.